Keywords: cocensys, novel, migraine, drug, effective, phase, ii

CoCensys' Novel Migraine Drug Effective In Phase II

Article | 25 February 1998

Print This

CoCensys has reported encouraging data from a placebo-controlled,double-blind Phase II clinical trial of its lead product ganaxolone for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in